Skip to content

Improving gait in hereditary spastic paraplegia: towards evidence-based and individually tailored rehabilitation

Improving gait in hereditary spastic paraplegia: towards evidence-based and individually tailored rehabilitation - MOVE-HSP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48504
Enrollment
36
Registered
2019-10-31
Start date
2019-12-02
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary spastic paraplegia (HSP) and Strumpell disease

Interventions

The intervention group will receive a 5-week C-mill, whereas the control group will first enter a 5-week waiting period of usual care, after which they receive the same 5-week C-mill training. Befor

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of pure HSP based on molecular diagnosis (e.g. SPG-4 mutations) or based on inheritance. - Age between 18 and 70 years old. - Being able to independently walk barefoot on a level ground for 50 meters without a walking aid (use of orthopaedic devices or made-to-measure footwear is allowed).

Exclusion criteria

Exclusion criteria: -Other neurological or serious orthopaedic or psychiatric co-morbidity as well as previous surgical interventions of the lower extremities.

Design outcomes

Primary

MeasureTime frame
Gait adaptability, as measured with the obstacle subtask of the Emory Functional Ambulation Profile (EFAP).

Secondary

MeasureTime frame
The secondary study parameters are the number of falls and the scores on the 10 meter walk test, 6min walk test and ladder gait test. In addition we will investigate whether individual improvement in gait adaptability as measured with the Mini-BEST test is statistically related to individual balance capacity, more than to lower extremity muscle strength or muscle tone. Furthermore, we will measure physical activity in daily life by wearable sensors.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)